CROI 2016 Program at a Glance

Program and Agenda

L. HIV Drug Resistance P-L1 HIV Drug Resistance: Surveillance andTransmission (Tuesday, February 23, 2016) P-L2 HIV Drug Resistance: Clinical and Epidemiologic Studies (Wednesday, February 24, 2016) P-L3 HIV Drug Resistance in Different Drug Classes (Thursday, February 25, 2016) P-L4 HIV-2 Drug Resistance (Thursday, February 25, 2016) M. HIV Diagnostics P-M1 HIV Diagnostics (Tuesday, February 23, 2016) P-M2 HIV Detection in ClinicalTrials (Wednesday, February 24, 2016) P-M3 Detecting HCV (Thursday, February 25, 2016) N. Hepatitis Viruses P-N1 HCV Staging: Stiffen Up! (Tuesday, February 23, 2016) P-N2 HCV Cure: Moving the Needle from the Patient to the Population (Tuesday, February 23, 2016) P-N3 HCVTransmissionTracking andTransmission Risks (Tuesday, February 23, 2016) P-N4 Progression of Liver Disease: Mediators and Moderators (Tuesday, February 23, 2016) P-N5 HBV Infection: Prevalence, Prevention, and Prognosticators (Wednesday, February 24, 2016) P-N6 HCV Infection:Therapeutic Studies and Drug Resistance (Wednesday, February 24, 2016) P-N7 HCVTherapeutics: Observational Experiences and“RealWorld” Studies (Wednesday, February 24, 2016) P-N8 Acute HCV Infection (Thursday, February 25, 2016) P-N9 Hepatitis A, D, and E (Thursday, February 25, 2016) P-N10 Pathogenesis of HCV Infection: Activation and Exhaustion (Thursday, February 25, 2016) P-N11 HCV:TheVirus is Gone;The Morbidity Not So Much (Thursday, February 25, 2016) P-N12 HCV Mischief from Beyond the Liver (Thursday, February 25, 2016) O. HIV-Related and Non–HIV-Related Malignancies P-O1 Global Burden and Mortality of Cancer in HIV (Wednesday, February 24, 2016) P-O2 Anal and Cervical Cancer:Treatment and Prevention (Wednesday, February 24, 2016) P-O3 Lymphoma and Kaposi Sarcoma (Thursday, February 25, 2016) P-O4 Other Cancers and Risk of Malignancies in HIV (Thursday, February 25, 2016)

P. Cardiovascular Complications of HIV Infection and Antiretroviral Therapy P-P1 Stroke: Incidence and Risk Factors (Tuesday, February 23, 2016) P-P2 Cardiovascular Disease: Risk, Prediction, Assessment, and Management (Tuesday, February 23, 2016) P-P3 Atherosclerosis Pathogenesis: Role of the Immune System (Wednesday, February 24, 2016) P-P4 Cardiovascular Disease and AntiretroviralTherapy Effects (Wednesday, February 24, 2016) P-P5 Cholesterol Metabolism (Thursday, February 25, 2016) P-P6 NRTIToxicities (Thursday, February 25, 2016) P-P7 Oxidized Lipids: AssociationsWith Outcomes and Impact of Interventions (Thursday, February 25, 2016) P-P8 Smoking: MoreWays It Can Harm (Thursday, February 25, 2016) P-P9 Noncommunicable Diseases in Low- and Middle- Income Countries (Thursday, February 25, 2016) Q. Other Complications of HIV Infection and Antiretroviral Therapy P-Q1 Renal Outcomes:TAF andTDF (Tuesday, February 23, 2016) P-Q2 Renal and Bone Disease: Risk Factors and Biomarkers (Tuesday, February 23, 2016) P-Q3 Bone Disease: Sticks, Stones, andTDF (Wednesday, February 24, 2016) P-Q4 Metabolic Complications (Wednesday, February 24, 2016) P-Q5 Multimorbidity and Aging (Wednesday, February 24, 2016) P-Q6 Aging and Immune Effects of AntiretroviralTherapy (Thursday, February 25, 2016) P-Q7 Frailty and Functional Status (Thursday, February 25, 2016) P-Q8 Mechanisms of Pulmonary Complications (Thursday, February 25, 2016) P-Q9 HerpesVirus Coinfections (Thursday, February 25, 2016) R. Tuberculosis and Other Opportunistic Infections P-R1 Tuberculosis: Pathogenesis Studies (Tuesday, February 23, 2016) P-R2 TuberculosisTransmission (Tuesday, February 23, 2016) P-R3 Implementation of HIV andTuberculosis Services (Tuesday, February 23, 2016) P-R4 Tuberculosis Related Outcomes and Mortality (Tuesday, February 23, 2016) P-R5 Diagnosis ofTuberculosis (Wednesday, February 24, 2016) P-R6 Tuberculosis and AntiretroviralTherapy (Wednesday, February 24, 2016) P-R7 Multidrug-ResistantTuberculosis (Wednesday, February 24, 2016) P-R8 Tuberculosis and Pregnancy (Wednesday, February 24, 2016) P-R9 Cryptococcal Disease: Detection and Outcomes (Thursday, February 25, 2016) P-R10 Other Infectious Complications of HIV Disease (Thursday, February 25, 2016)

Poster Sessions

51

CROI 2016